Atrial Fibrillation and Supraventricular Tachycardia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia who are scheduled for radiofrequency ablation and meet the procedure indications; 2.Patients aged 18–80 years; 3.Patients who can provide written informed consent and comply with perioperative and follow-up requirements; 4.Patients with clear electrocardiographic diagnostic evidence.
Exclusion criteria
Exclusion criteria: 1.Patients with acute heart failure; 2.Patients with coagulation dysfunction; 3.Patients with left atrial thrombus; 4.Patients with severe liver or renal dysfunction; 5.Patients who have previously undergone cardiac surgery; 6.Patients who have previously undergone catheter ablation for atrial fibrillation or supraventricular tachycardia; 7.Patients with complex congenital heart disease; 8.Pregnant female patients; 9.Patients with cardiovascular structural abnormalities that may affect catheter placement, such as femoral vein malformations; 10.Patients with implanted devices that may interfere with catheter manipulation, such as atrial septal defect occluders, pacemakers, or pacemaker leads; 11.Patients requiring X-ray fluoroscopy during the procedure, such as vein of marshall ethanol ablation or left atrial appendage closure; 12.Patients currently participating in other interventional studies; 13.Patients deemed unsuitable for this study by the investigator;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of procedure-related complications;Immediate procedure success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| procedure time;Recurrence rate;X-ray fluoroscopy parameters;Hospitalization costs; | — |
Countries
China
Contacts
The first affiliated hospital of anhui medical university